GSK Aktie
18,65
EUR
-0,02
EUR
-0,11
%
16,25
GBP
-0,09
GBP
-0,55
%
Werbung
GSK Aktie Analyse
01.06.05 | GSK underweight | Prudential Financial | |
01.05.05 | GSK Halten | Helaba Trust | |
28.04.05 | GSK In-Line | Goldman Sachs | |
28.04.05 | GSK Kaufen | BHF-BANK | |
26.04.05 | GSK Sector Underperform | Vontobel | |
25.04.05 | GSK In-Line | Goldman Sachs | |
24.04.05 | GSK Halten | Helaba Trust | |
17.04.05 | GSK In-Line | Goldman Sachs | |
Werbung
|
|||
17.04.05 | GSK Overweight | Lehman Brothers | |
14.04.05 | GSK Neutral | HypoVereinsbank | |
06.03.05 | GSK In-Line | Goldman Sachs | |
06.03.05 | GSK Overweight | Lehman Brothers | |
03.03.05 | GSK Outperform | Credit Suisse First Boston | |
15.02.05 | GSK Kaufen | LB Baden-Württemberg | |
13.02.05 | GSK In-Line | Goldman Sachs | |
13.02.05 | GSK Halten | Helaba Trust | |
13.02.05 | GSK Outperformer | Sparkasse KölnBonn | |
10.02.05 | GSK Halten | Helaba Trust | |
10.02.05 | GSK Reduzieren | Independent Research | |
10.02.05 | GSK Outperform | Credit Suisse First Boston | |
09.02.05 | GSK Outperform | Credit Suisse First Boston | |
06.02.05 | GSK Outperform | Credit Suisse First Boston | |
02.02.05 | GSK Halten | Helaba Trust | |
19.01.05 | GSK Underweight | Morgan Stanley | |
17.01.05 | GSK Buy | Merrill Lynch | |
27.01.04 | GSK In-Line | Goldman Sachs |
Werbung
Werbung